We are live on ! Find out more
KM

Kalos Management Portfolio holdings

AUM $46.6M
1-Year Est. Return 11.52%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+11.52%
3 Year Est. Return
+48.48%
5 Year Est. Return
+71.6%
10 Year Est. Return
AUM
$220M
AUM Growth
+$65.3M
Cap. Flow
+$74.6M
Cap. Flow %
33.91%
Top 10 Hldgs %
28.53%
Holding
203
New
50
Increased
127
Reduced
16
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 10.37%
2 Healthcare 9.03%
3 Financials 7.61%
4 Consumer Discretionary 4.79%
5 Real Estate 3.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOLD
176
DELISTED
Amicus Therapeutics
FOLD
$135K 0.06%
10,850
+3,194
+42% +$40.5K
GE icon
177
GE Aerospace
GE
$374B
$130K 0.06%
2,661
+177
+7% +$8.71K
GYRE icon
178
Gyre Therapeutics
GYRE
$641M
$127K 0.06%
2,308
+157
+7% +$9.81K
PRTK
179
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$119K 0.05%
30,050
+3,483
+13% +$16.6K
HTGM
180
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$111K 0.05%
372
+18
+5% +$7.51K
CTSO icon
181
Cytosorbents Corp
CTSO
$22.7M
$89K 0.04%
13,500
-608
-4% -$4.18K
PSLV icon
182
Sprott Physical Silver Trust
PSLV
$12B
$70K 0.03%
+12,367
New +$66.8K
SACH
183
Sachem Capital Corp
SACH
$39.1M
$58K 0.03%
+11,000
New +$53.3K
VSTM icon
184
Verastem
VSTM
$510M
$44K 0.02%
+2,438
New +$55.2K
NGNE icon
185
Neurogene
NGNE
$656M
$35K 0.02%
+745
New +$38.3K
SNMP
186
DELISTED
Evolve Transition Infrastructure LP
SNMP
$35K 0.02%
+526
New +$36.3K
PFX icon
187
PhenixFIN
PFX
$31K 0.01%
+675
New +$39.4K
AUY
188
DELISTED
Yamana Gold, Inc.
AUY
$25K 0.01%
+10,624
New +$23.4K
HSTO
189
DELISTED
Histogen Inc. Common Stock
HSTO
$12K 0.01%
+238
New +$41.3K
MTVA
190
MetaVia Inc
MTVA
$7.33M
0
ARCC icon
191
Ares Capital
ARCC
$13.5B
-12,254
Closed -$210K
BCRX icon
192
BioCryst Pharmaceuticals
BCRX
$2.28B
-27,443
Closed -$223K
DBC icon
193
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
-9,571
Closed -$152K
DBRG icon
194
DigitalBridge
DBRG
$2.93B
-4,935
Closed -$105K
IJT icon
195
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.26B
-2,702
Closed -$241K
PG icon
196
Procter & Gamble
PG
$336B
-2,625
Closed -$273K
VUG icon
197
Vanguard Morningstar Growth ETF
VUG
$220B
-7,236
Closed -$188K

Similar funds

Kalos Management's Q2 2019 Portfolio in Review

As of Q2 2019, Kalos Management held 203 positions worth $220M, up 42% from $155M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Kalos Management deployed $74.6M of net new capital in Q2 2019, opening 50 new positions and adding to 127 existing holdings. Its largest new stake was Schwab US Broad Market ETF: 617,280 shares worth $7.3M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $1.95M trimmed.

  • Kalos Management's largest Q2 2019 buy was Schwab US Broad Market ETF: 617,280 shares worth $7.3M.
  • Kalos Management added most to VEREIT, Inc. in Q2 2019, an estimated $3.74M increase.
  • Kalos Management's biggest Q2 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.95M.
  • Kalos Management fully exited Procter & Gamble in Q2 2019, selling an estimated $273K.
  • Kalos Management's ten largest holdings make up 29% of its $220M portfolio in Q2 2019.
  • Kalos Management opened 50 new positions and closed 9 in Q2 2019.
  • Kalos Management's portfolio value rose 42% quarter-over-quarter to $220M.

Based on Kalos Management's 13F filing for Q2 2019, filed 14 Aug 2019.